JP Morgan Chase
SLS icon

JP Morgan Chase’s SELLAS Life Sciences SLS Stock Holding History

JP Morgan Chase’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
100,135
+18,311
+22% +$126K ﹤0.01% 4383
2026
Q1 		$328K Buy
81,824
+32,345
+65% +$145K ﹤0.01% 5235
2025
Q4 		$187K Buy
49,479
+8,757
+22% +$17K ﹤0.01% 5577
2025
Q3 		$65.6K Sell
40,722
-21,170
-34% -$37.7K ﹤0.01% 6123
2025
Q2 		$136K Buy
+61,892
New +$95K ﹤0.01% 5458
2024
Q4 		– Sell
-5,789
Closed -$7.24K – 7700
2024
Q3 		$7.24K Buy
+5,789
New +$7.08K ﹤0.01% 6422
2024
Q2 		– Sell
-6,092
Closed -$6.15K – 7715
2024
Q1 		$6.15K Sell
6,092
-3,701
-38% -$3.11K ﹤0.01% 6411
2023
Q4 		$10.4K Buy
9,793
+5,759
+143% +$6.23K ﹤0.01% 6391
2023
Q3 		$6.62K Buy
4,034
+2,034
+102% +$3.21K ﹤0.01% 6329
2023
Q2 		$3.14K Buy
+2,000
New +$3.21K ﹤0.01% 6270
2022
Q4 		– Sell
-3,550
Closed -$7K – 6956
2022
Q3 		$7K Hold
3,550
– – ﹤0.01% 6041
2022
Q2 		$8K Buy
+3,550
New +$10.4K ﹤0.01% 6076
2021
Q3 		– Sell
-876
Closed -$10K – 6766
2021
Q2 		$10K Buy
+876
New +$8.55K ﹤0.01% 6037
2017
Q2 		– Sell
-14
Closed -$13K – 5196
2017
Q1 		$13K Buy
14
+4
+40% +$6.62K ﹤0.01% 4774
2016
Q4 		$29K Buy
+10
New +$58.1K ﹤0.01% 4640

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

JP Morgan Chase's SLS Position: Q2 2026 in Review

JP Morgan Chase increased its SELLAS Life Sciences (SLS) stake by 22% in Q2 2026, buying an estimated $126K and bringing the position to 100,135 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4383.

JP Morgan Chase first reported a position in SLS in Q4 2016 and has held it in 15 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • JP Morgan Chase held 100,135 shares of SELLAS Life Sciences worth $1.55M as of Q2 2026.
  • JP Morgan Chase bought 18,311 SELLAS Life Sciences shares in Q2 2026, an estimated $126K.
  • SELLAS Life Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4383 holding.
  • JP Morgan Chase first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 15 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.